Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Перспективные терапевтические мишени для лечения ревматоидного артрита
2021-07-09
SCID: 54.1/9dcwedaz
Discuss with AI
Disease-modifying antirheumatic drugsEpigenetic regulatorsRheumatoid arthritisSmall molecular metabolitesTherapeutic targets
Figures from the paper
Abstract (AI)
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients. Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies. Understanding the pathogenetic roles of the various molecules in RA could facilitate discovery of potential therapeutic targets and approaches. In this review, both existing and emerging targets, including the proteins, small molecular metabolites, and epigenetic regulators related to RA, are discussed, with a focus on the mechanisms that result in inflammation and the development of new drugs for blocking the various modulators in RA.
Key Findings
1
DMARDs substantially prevent and relieve RA disease activity, but some patients show limited therapeutic responses.
2
Developing drugs that block these molecular modulators represents a strategy for addressing inadequate DMARD responses.
3
Potential RA targets include proteins, small-molecule metabolites, and epigenetic regulators involved in inflammation and disease development.
4
Rheumatoid arthritis affects approximately 0.5% to 1.0% of the worldwide population and primarily damages the hands and feet.
5
Understanding the pathogenic roles of RA-associated molecules can enable discovery of specialized therapeutic targets and novel treatments.
Research Object
Rheumatoid arthritis and its associated molecular targets, including proteins, small-molecule metabolites, and epigenetic regulators
Research Subject
The pathogenetic roles of molecular targets in RA, their mechanisms of driving inflammation, and their potential for therapeutic intervention
Publication Details
Publication Date
2021-07-09
Journal
Publisher
ISSN
Cited by
371
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest